Maya Jribi

Recent publications · Crossref

5 total works indexed

1. Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

   · 2016 · cited 8,504x

2. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015

   · 2016 · cited 5,039x

3. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

   · 2014 · cited 4,489x

4. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

   · 2020 · cited 3,934x

5. Mdm2 promotes the rapid degradation of p53

   · 1997 · cited 3,728x

via Crossref · CC0